You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

Details for New Drug Application (NDA): 075089

✉ Email this page to a colleague

« Back to Dashboard

NDA 075089 describes TICLOPIDINE HYDROCHLORIDE, which is a drug marketed by Actavis Elizabeth, Apotex, Chartwell Rx, Mylan, Natco Pharma, Sun Pharm Inds Inc, Teva, and Watson Labs, and is included in nine NDAs. Additional details are available on the TICLOPIDINE HYDROCHLORIDE profile page.

The generic ingredient in TICLOPIDINE HYDROCHLORIDE is ticlopidine hydrochloride. There are nine drug master file entries for this compound. Additional details are available on the ticlopidine hydrochloride profile page.

Summary for 075089

Tradename:	TICLOPIDINE HYDROCHLORIDE
Applicant:	Apotex
Ingredient:	ticlopidine hydrochloride
Patents:	0

Medical Subject Heading (MeSH) Categories for 075089

Cytochrome P-450 CYP2C19 Inhibitors
Fibrinolytic Agents
Platelet Aggregation Inhibitors
Purinergic P2Y Receptor Antagonists

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	250MG
Approval Date:	Jul 1, 1999	TE:		RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.